Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Raun: Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and.... (0.11 sec) 

Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food …

- diabetesjournals.org
K Raun, P von Voss, CF Gotfredsen, V … - Diabetes, 2007 - Am Diabetes Assoc
Metabolic effects of the glucagon-like peptide-1 analog liraglutide and the
dipeptidyl peptidase-IV inhibitor vildagliptin were compared in rats made obese
by supplementary candy feeding. Female Sprague-Dawley rats were randomized ...
Cited by 16 - Related articles - BL Direct - All 7 versions

Liraglutide, a Once-daily Human Glucagon-like Peptide-1 Analog, Minimizes Food Intake in …


K Raun, P von Voss, LB Knudsen - Obesity, 2007 - nature.com
* The costs of publication of this article were defrayed, in part, by the
payment of page charges. This article must, therefore, be hereby marked
"advertisement" in accordance with 18 USC Section 1734 solely to indicate ...
Cited by 10 - Related articles - All 3 versions

[CITATION] 3.5 years of exenatide maintained progressive weight reduction was associated with …


A Stonehouse, X Guan, J Holcombe, T … - Obesity (Silver Spring): Abstract, 2007
Cited by 3 - Related articles

[CITATION] J DD: The classic incretin receptors for GLP-1 and GIP are essential for the sustained …


G Flock, GL Zhang, A Duttaroy - Diabetologia, 2006
Cited by 3 - Related articles

[CITATION] The molecular basis for the delayed absorption of the once-daily human GLP-1 analogue, …


DB Steensgaard, JK Thomsen, HB Olsen, LB … - Diabetes, 2008
Cited by 3 - Related articles

Inhibition of dipeptidyl-peptidase IV does not increase circulating IGF-1 concentrations in …

- ebmonline.org
TD Faidley, B Leiting, KD Pryor, K Lyons, … - Experimental Biology and Medicine, 2006 - SEBM
The enzyme dipeptidyl peptidase-IV (DPP-IV) inactivates a variety of bioactive
peptides, including glucagon-like peptide-1 (GLP-1) and growth hormone releasing
hormone (GHRH). Inhibiting DPP-IV in order to increase circulating GLP-1 is ...
Cited by 4 - Related articles - BL Direct - All 3 versions

[CITATION] Derivatives of glucagon-like peptide-1 suitable for once daily administration


LB Knudsen, H Agerso, PO Huusfeldt, PF … - Diabetes, 1999
Cited by 5 - Related articles

Higher fasting plasma concentrations of glucagon-like peptide 1 are associated with higher …

- ajcn.org
N Pannacciulli, JC Bunt, J Koska, C Bogardus, … - American Journal of Clinical Nutrition, 2006 - Am Soc Nutrition
Design: Forty-six glucose-tolerant white subjects (22 men, 24 women) aged
18–49 y whose adiposity spanned a wide range [body mass index (in kg/m 2 ):
18.5–50] were studied in an inpatient clinic. Main outcome measures ...
Cited by 6 - Related articles - BL Direct - All 8 versions

Inhibition of DPP-4 augments insulin secretion in response to exogenously administered …

- endojournals.org [PDF] 
BO AHREN, TE HUGHES - Endocrinology, 2004 - Endocrine Soc
Page 1. 1 Inhibition of DPP-4 Augments Insulin Secretion in Response to
Exogenously Administered GLP-1, GIP, PACAP and GRP in Mice ...
Cited by 7 - Related articles

[CITATION] Induction of glucose competence in pancreatic beta cells by glucagon-like peptide-1 (7-37)


GHT Holz, WM Kuhtreiber, JF Habener - Trans Assoc Am Physicians, 1992 - grande.nal.usda.gov
Title: Induction of glucose competence in pancreatic beta cells by glucagon-like
peptide-1(7-37). Author: Holz, GH : Kuhtreiber, WM : Habener, JF Citation:
Trans-Assoc-Am-Physicians. 1992; 105260-7 Abstract: None Review References: ...
Cited by 8 - Related articles - Cached - BL Direct - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google